Department of Reproductive Health and Research, World Health Organization, Geneva, Switzerland.
Knowledge Centre for the Health Services, Norwegian Institute of Public Health, Oslo, Norway.
BJOG. 2017 Jan;124(2):200-208. doi: 10.1111/1471-0528.14248. Epub 2016 Aug 23.
The contraceptive injectable is a safe and effective method that is used worldwide. With the variety of injectable delivery systems, there is potential for administration by the woman herself. Self-administration of the contraceptive injectable is the subject of this systematic review.
To assess how effective and safe the contraceptive injectable method is when women themselves perform/administer it, compared with when the usual healthcare providers administer it.
We searched PubMed, Popline, Cochrane, CINAHL, and Embase for articles with subject headings or text words related to 'self-administration' and 'contraception'.
Studies that compared the administration of the contraceptive injectable by the woman herself versus administration by the healthcare provider were included. Outcomes of interest were continuation rates, safety, and the women's overall satisfaction with the contraceptive provider and method.
We undertook data extraction, descriptive analysis, and assessment of risk of bias.
Three studies met the inclusion criteria. The best available evidence shows that there may be little or no difference in continuation rates when women self-administer contraceptive injections (326 per 1000 women; 95% CI 192-554 per 1000 women) compared with administration by healthcare providers (304 per 1000 women). Safety was not estimable as no serious adverse events were reported in any of the studies. With regards to overall satisfaction towards the provider and the method, the effect of the intervention was uncertain.
AUTHORS' CONCLUSIONS: Findings suggest that with appropriate information and training the provision of contraceptive injectables for the woman to self-administer at home can be an option in some contexts.
This review assessed the continuation rates and safety of self-administration of the contraceptive injection.
避孕注射剂是一种安全有效的方法,在全球范围内使用。随着各种注射剂输送系统的出现,女性自己进行注射是有可能的。本次系统评价的主题是避孕注射剂的自我管理。
评估女性自己进行避孕注射与通常由医疗保健提供者进行注射相比,该方法的有效性和安全性如何。
我们在 PubMed、Popline、Cochrane、CINAHL 和 Embase 中搜索了与“自我管理”和“避孕”相关的主题词或文本的文章。
纳入了将避孕注射剂由女性自己管理与由医疗保健提供者管理进行比较的研究。感兴趣的结果是续用率、安全性以及女性对避孕提供者和方法的总体满意度。
我们进行了数据提取、描述性分析和偏倚风险评估。
有三项研究符合纳入标准。现有最佳证据表明,当女性自行注射避孕针时,续用率可能相差不大或没有差异(每 1000 名妇女中有 326 人;95%置信区间每 1000 名妇女中有 192-554 人),与由医疗保健提供者进行注射相比(每 1000 名妇女中有 304 人)。由于没有研究报告任何严重不良事件,因此无法评估安全性。关于对提供者和方法的总体满意度,干预效果不确定。
研究结果表明,在适当的信息和培训下,在某些情况下,为女性提供在家自行注射避孕针的选择是可行的。
本综述评估了自我管理避孕注射的续用率和安全性。